Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab.

Authors

null

Yoshiaki Yamamoto

Yamaguchi University Graduate School of Medicine, Ube, Japan

Yoshiaki Yamamoto , Hideyasu Matsuyama , Hiroaki Matsumoto , Shigeru Sakano , Nakanori Fujii , Kazuo Oba , Mitsutaka Yamamoto , Yoriaki Kamiryo , Takeshi Hiragino , Kazuhiro Nagao , Kimio Takai , Akihiko Aoki , Satoru Yoshihiro , Manabu Tsukamoto , Jumpei Akao , Seiji Kitahara , Taku Misumi , Hirotaka Komatsu , Shintaro Oka , Akinobu Suga

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 724)

Abstract #

724

Poster Bd #

H22

Abstract Disclosures